nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—polycystic ovary syndrome	0.827	1	CbGaD
Dicyclomine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00181	0.0524	CcSEcCtD
Dicyclomine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00161	0.0466	CcSEcCtD
Dicyclomine—Lethargy—Metformin—polycystic ovary syndrome	0.0015	0.0434	CcSEcCtD
Dicyclomine—Breast disorder—Metformin—polycystic ovary syndrome	0.00132	0.0384	CcSEcCtD
Dicyclomine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00128	0.037	CcSEcCtD
Dicyclomine—Drowsiness—Metformin—polycystic ovary syndrome	0.00113	0.0327	CcSEcCtD
Dicyclomine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00101	0.0293	CcSEcCtD
Dicyclomine—Eye disorder—Metformin—polycystic ovary syndrome	0.000948	0.0275	CcSEcCtD
Dicyclomine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000941	0.0273	CcSEcCtD
Dicyclomine—Immune system disorder—Metformin—polycystic ovary syndrome	0.000916	0.0266	CcSEcCtD
Dicyclomine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000914	0.0265	CcSEcCtD
Dicyclomine—Erythema—Metformin—polycystic ovary syndrome	0.000883	0.0256	CcSEcCtD
Dicyclomine—Vision blurred—Metformin—polycystic ovary syndrome	0.000832	0.0241	CcSEcCtD
Dicyclomine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000819	0.0237	CcSEcCtD
Dicyclomine—Malaise—Metformin—polycystic ovary syndrome	0.000796	0.0231	CcSEcCtD
Dicyclomine—Syncope—Metformin—polycystic ovary syndrome	0.000792	0.023	CcSEcCtD
Dicyclomine—Palpitations—Metformin—polycystic ovary syndrome	0.00078	0.0226	CcSEcCtD
Dicyclomine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000776	0.0225	CcSEcCtD
Dicyclomine—Hypertension—Metformin—polycystic ovary syndrome	0.000762	0.0221	CcSEcCtD
Dicyclomine—Discomfort—Metformin—polycystic ovary syndrome	0.000743	0.0215	CcSEcCtD
Dicyclomine—Oedema—Metformin—polycystic ovary syndrome	0.00072	0.0209	CcSEcCtD
Dicyclomine—Shock—Metformin—polycystic ovary syndrome	0.000709	0.0205	CcSEcCtD
Dicyclomine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000707	0.0205	CcSEcCtD
Dicyclomine—Anorexia—Metformin—polycystic ovary syndrome	0.000687	0.0199	CcSEcCtD
Dicyclomine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000647	0.0188	CcSEcCtD
Dicyclomine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000642	0.0186	CcSEcCtD
Dicyclomine—Somnolence—Metformin—polycystic ovary syndrome	0.00064	0.0186	CcSEcCtD
Dicyclomine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000634	0.0184	CcSEcCtD
Dicyclomine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000626	0.0182	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000622	0.018	CcSEcCtD
Dicyclomine—Fatigue—Metformin—polycystic ovary syndrome	0.000621	0.018	CcSEcCtD
Dicyclomine—Constipation—Metformin—polycystic ovary syndrome	0.000616	0.0179	CcSEcCtD
Dicyclomine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000594	0.0172	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000589	0.0171	CcSEcCtD
Dicyclomine—Urticaria—Metformin—polycystic ovary syndrome	0.000572	0.0166	CcSEcCtD
Dicyclomine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00057	0.0165	CcSEcCtD
Dicyclomine—Asthenia—Metformin—polycystic ovary syndrome	0.000517	0.015	CcSEcCtD
Dicyclomine—Pruritus—Metformin—polycystic ovary syndrome	0.00051	0.0148	CcSEcCtD
Dicyclomine—Dizziness—Metformin—polycystic ovary syndrome	0.000476	0.0138	CcSEcCtD
Dicyclomine—Vomiting—Metformin—polycystic ovary syndrome	0.000458	0.0133	CcSEcCtD
Dicyclomine—Rash—Metformin—polycystic ovary syndrome	0.000454	0.0132	CcSEcCtD
Dicyclomine—Dermatitis—Metformin—polycystic ovary syndrome	0.000454	0.0132	CcSEcCtD
Dicyclomine—Headache—Metformin—polycystic ovary syndrome	0.000451	0.0131	CcSEcCtD
Dicyclomine—Nausea—Metformin—polycystic ovary syndrome	0.000428	0.0124	CcSEcCtD
Dicyclomine—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.92e-05	0.000574	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—GNAS—polycystic ovary syndrome	7.92e-05	0.000574	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.9e-05	0.000572	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.87e-05	0.00057	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	7.85e-05	0.000568	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.84e-05	0.000568	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.82e-05	0.000566	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.8e-05	0.000565	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.77e-05	0.000562	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	7.66e-05	0.000555	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	7.66e-05	0.000555	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SRD5A1—polycystic ovary syndrome	7.66e-05	0.000555	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	7.61e-05	0.000551	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	7.54e-05	0.000546	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—SCT—polycystic ovary syndrome	7.52e-05	0.000544	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.47e-05	0.000541	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.47e-05	0.000541	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	7.45e-05	0.000539	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.44e-05	0.000539	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.44e-05	0.000539	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.37e-05	0.000534	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.37e-05	0.000534	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.37e-05	0.000533	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—STAR—polycystic ovary syndrome	7.31e-05	0.000529	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.25e-05	0.000525	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.2e-05	0.000521	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.17e-05	0.000519	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.1e-05	0.000514	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.03e-05	0.000509	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.01e-05	0.000507	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.99e-05	0.000506	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.96e-05	0.000504	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.94e-05	0.000502	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.9e-05	0.000499	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.78e-05	0.000491	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.76e-05	0.000489	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.69e-05	0.000485	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.6e-05	0.000478	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.58e-05	0.000476	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	6.52e-05	0.000472	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.51e-05	0.000471	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.43e-05	0.000465	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	6.42e-05	0.000465	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	6.41e-05	0.000464	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.35e-05	0.000459	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	6.22e-05	0.00045	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	6.09e-05	0.000441	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6e-05	0.000434	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.98e-05	0.000433	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.92e-05	0.000429	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.85e-05	0.000424	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.83e-05	0.000422	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	5.81e-05	0.00042	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.78e-05	0.000418	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.74e-05	0.000416	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LHB—polycystic ovary syndrome	5.67e-05	0.00041	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	5.54e-05	0.000401	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.47e-05	0.000396	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	5.45e-05	0.000394	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.4e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	5.37e-05	0.000388	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.35e-05	0.000387	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	5.34e-05	0.000386	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.31e-05	0.000385	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.3e-05	0.000384	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.28e-05	0.000382	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.26e-05	0.000381	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.25e-05	0.00038	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	5.18e-05	0.000375	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.14e-05	0.000372	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.12e-05	0.000371	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.07e-05	0.000367	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5e-05	0.000362	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.98e-05	0.000361	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	4.94e-05	0.000358	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.94e-05	0.000358	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.94e-05	0.000357	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.88e-05	0.000353	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	4.87e-05	0.000353	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	4.86e-05	0.000352	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.84e-05	0.000351	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.83e-05	0.00035	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.81e-05	0.000348	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	4.81e-05	0.000348	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.8e-05	0.000347	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	4.78e-05	0.000346	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.78e-05	0.000346	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	4.76e-05	0.000344	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.75e-05	0.000344	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	4.74e-05	0.000343	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	4.69e-05	0.00034	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.65e-05	0.000336	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.63e-05	0.000335	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	4.61e-05	0.000334	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.59e-05	0.000332	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	4.5e-05	0.000326	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.5e-05	0.000326	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.49e-05	0.000325	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.49e-05	0.000325	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.48e-05	0.000324	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	4.46e-05	0.000323	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.44e-05	0.000322	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	4.44e-05	0.000322	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.43e-05	0.000321	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	4.43e-05	0.000321	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	4.4e-05	0.000319	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.4e-05	0.000318	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	4.4e-05	0.000318	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.39e-05	0.000317	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	4.37e-05	0.000317	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.35e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.34e-05	0.000314	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.26e-05	0.000309	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.25e-05	0.000308	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.24e-05	0.000307	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.2e-05	0.000304	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.18e-05	0.000302	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.16e-05	0.000301	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.14e-05	0.0003	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	4.13e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.13e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.12e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.12e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.11e-05	0.000298	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.09e-05	0.000296	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.08e-05	0.000295	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	4.07e-05	0.000294	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.07e-05	0.000294	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.03e-05	0.000291	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.92e-05	0.000284	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.87e-05	0.00028	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	3.86e-05	0.000279	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.82e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.81e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.8e-05	0.000275	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	3.8e-05	0.000275	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.77e-05	0.000273	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	3.66e-05	0.000265	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	3.65e-05	0.000264	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	3.64e-05	0.000263	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	3.6e-05	0.000261	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TH—polycystic ovary syndrome	3.52e-05	0.000255	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	3.52e-05	0.000255	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.5e-05	0.000253	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.48e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.47e-05	0.000251	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.45e-05	0.00025	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.45e-05	0.00025	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	3.42e-05	0.000248	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.42e-05	0.000248	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.41e-05	0.000247	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.4e-05	0.000246	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	3.38e-05	0.000244	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.37e-05	0.000244	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	3.37e-05	0.000244	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	3.33e-05	0.000241	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.28e-05	0.000238	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.23e-05	0.000234	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	3.22e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.14e-05	0.000227	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.14e-05	0.000227	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.13e-05	0.000227	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.13e-05	0.000227	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.1e-05	0.000224	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.1e-05	0.000224	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.02e-05	0.000219	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.02e-05	0.000218	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	3e-05	0.000217	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.99e-05	0.000216	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.99e-05	0.000216	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.96e-05	0.000214	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.92e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.91e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.91e-05	0.00021	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.9e-05	0.00021	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.88e-05	0.000209	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	2.87e-05	0.000208	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.87e-05	0.000208	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TH—polycystic ovary syndrome	2.8e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.76e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.76e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.75e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	2.74e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.74e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	2.74e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	2.73e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.73e-05	0.000198	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.72e-05	0.000197	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.71e-05	0.000196	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	2.7e-05	0.000196	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.64e-05	0.000191	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.63e-05	0.000191	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.61e-05	0.000189	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.6e-05	0.000188	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	2.59e-05	0.000188	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.59e-05	0.000188	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.57e-05	0.000186	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.56e-05	0.000185	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	2.42e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.41e-05	0.000174	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.4e-05	0.000174	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.38e-05	0.000172	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.3e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.29e-05	0.000166	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	2.28e-05	0.000165	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.27e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.25e-05	0.000163	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.25e-05	0.000163	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.22e-05	0.000161	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	2.17e-05	0.000157	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	1.96e-05	0.000142	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	1.93e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.93e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.92e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—polycystic ovary syndrome	1.92e-05	0.000139	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.91e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	1.89e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	1.88e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	1.86e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.68e-05	0.000122	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.68e-05	0.000122	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.66e-05	0.00012	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	1.62e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	1.62e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	1.61e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	1.61e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.6e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	1.59e-05	0.000115	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.56e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.56e-05	0.000113	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	1.56e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.56e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.55e-05	0.000113	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.54e-05	0.000112	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.54e-05	0.000111	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	1.54e-05	0.000111	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	1.53e-05	0.000111	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.48e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.48e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.46e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.19e-05	8.64e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.19e-05	8.61e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.18e-05	8.53e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.02e-05	7.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.02e-05	7.36e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.01e-05	7.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	7.05e-06	5.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	7.03e-06	5.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	6.96e-06	5.04e-05	CbGpPWpGaD
